
New Focus on Fellows and Early-Career EPs article by @DrHaloot Finding value in the third year of cardiology fellowship in the new age of an accelerated pathway to electrophysiology heartrhythmcasereports.com/article/S2214-…
BCM Cardiology
968 posts

@BCMHeart
The Section of Cardiology at @BCMHouston is nationally and internationally recognized for its outstanding clinical and scientific research programs.

New Focus on Fellows and Early-Career EPs article by @DrHaloot Finding value in the third year of cardiology fellowship in the new age of an accelerated pathway to electrophysiology heartrhythmcasereports.com/article/S2214-…






In @LipidJournal we discuss our experience @BCMHeart of the impact of genetic testing for FH on clinical practice: - Majority diagnoses by clinical criteria before testing ⬇️ LDL-C ⬆️ PCSK9i prescriptions @CBallantyneMD @LaylaAbushamat @vijay_nambi sciencedirect.com/science/articl…

Our latest review in @ATHjournal looks at current and upcoming advances in PCSK9 inhibition for LDL-C lowering & ASCVD prevention: mAbs → siRNA → oral agents → gene editing. #CardioTwitter #Lipidology #PCSK9 @brettsmansfield @CBallantyneMD atherosclerosis-journal.com/article/S0021-…

Now on @Medscape : @CBallantyneMD discusses why statins alone aren’t always enough. Watch the full discussion: lnkd.in/gCsPcxg3 #Cardiology #Cholesterol #LDL #PreventiveCardiology #HeartHealth #Medscape #BaylorCollegeOfMedicine #TexasHeart

Where is cardiovascular science headed next? @CBallantyneMD joined fellow AHA 2025 Distinguished Scientist honorees on Aha! with @JAHA_AHA to discuss discovery, career journeys, and what’s ahead for the field. 🎥 Watch: youtube.com/watch?v=-HcSSy…



Oral PCSK9 Therapy And The Future Of Heart Disease - Dr. Christie M. Ballantyne, MD - @CBallantyneMD @bcmhouston & Dr. Alexander Tal, MD @ProgressPotent1 @irat1onal @Merck @RealChemistry_ #Cardiology #Atherosclerosis #HeartDiseasePrevention #Enlicitide #PCSK9 - youtube.com/watch?v=ANPedC…











We are accepting applications for our preventive cardiology fellowship at Baylor College of Medicine. Pl submit applications to vnambi@bcm.edu by dec 6 if interested @CBallantyneMD @LaylaAbushamat @ASPCardio @nationallipid

🎙️NEW #AHA25 #LBCT Interview 🌟 Dr @CBallantyneMD discusses findings from the CORALreef #HeFH trial, investigating safety and efficacy of oral #PCSK9 inhibitor, enlicitide decanoate, in familial #hypercholesterolemia and high-risk patients. 📽️Watch here👉 ow.ly/qF5X50Xp5yb 📊Findings included around 50% reductions in apolipoprotein B, reductions in LDL cholesterol, and a good safety profile. #AHA2025 #CardioEd


